← SynDRA
BW A4C
SynDRA canonical compound SYN1953250 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ALOX5 |
|---|
| Mechanism of action | lipoxygenase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- lipoxygenase inhibitor
- ALOX5 INHIBITOR
Cross-references
Synonyms
- BW-A4C
- BW4C
- Bwa 4C
- BWA4C
- CHEMBL314360
- C17H17NO3
- N-(E)-3-(3-Phenoxyphenyl)prop-2-enylacetohydroxamine acid
- Acetamide, N-hydroxy-N-(3-(3-phenoxyphenyl)-2-propenyl)-
- N-[(E)-3-(3-Phenoxyphenyl)prop-2-enyl]acetohydroxamic acid
- Acetohydroxamine acid, N-(E)-3-(3-phenoxyphenyl)prop-2-enyl-
- Acetamide, N-hydroxy-N-(3-(3-phenoxyphenyl)-2-propenyl)-, (E)-
- BW-4AC
- AC1O5PJ5
- BW-A 4C
- JMC515449 Compound 7
- BDBM22334
- ZINC5138195
- MFCD00869694
- N-(3-phenoxycinnamyl)-N-hydroxyacetamide
Look up BW A4C in the interactive SynDRA portal →